(833) 317-6278 
By: Natalie Bellini, Diana Isaacs
Brian Hansen, president of CGM at Ascensia Diabetes Care, joins the podcast to discuss the FDA clearance of the Eversense 365 CGM.
United States (National)
Diana Isaacs
Geo Focus
Coverage Attributes:
Beta
Cites Data:
44
%
Press Release:
28
%
Expert Commentary:
8
%
Announcement:
5
%
Industry Specific:
5
%
Themes Covered:
Not enough data
Pitching Insights
Diana Isaacs covers a range of topics related to diabetes, healthcare, and pharmaceuticals. Her articles heavily rely on cited data and announcements, indicating that she is likely to be interested in pitches backed by credible research findings or significant industry developments.
Given the technical nature of her coverage, Diana would benefit from outreach from experts who can provide detailed insights into new diabetes treatments, medical technologies, and updates in standards of care for diabetic patients. Sources with access to cutting-edge research or those involved in developing new pharmaceuticals may find success reaching out to her.
While no specific geographic focus is mentioned for Diana's coverage area, it seems global due to the nature of medical advancements being discussed without any regional limitations.
This information evolves through artificial intelligence and human feedback. Improve this profile .
Journalists With Similar Coverage:
Based on similarity of content.
Publications
Most recent topics
Not enough data
Publications
Most recent topics
Not enough data
Publications
Most recent topics
Not enough data
Publications
Most recent topics
Not enough data
Publications
Most recent topics
Not enough data
